Andrew Reardon is CLO & Secretary at LIGAND PHARMACEUTICALS INC (LGND). They have made 8 open-market trades across 1 company since 2023, most recently 2026-10-02.
CIK 0001950232
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LGND | 31,854 | $9.4M |
Shares reported on the most recent Form 4, priced at the 2026-10-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LGND | SELL · 10b5-1 | 2026-10-02 | 2026-10-06 | $304.07 | $1.5M | -1.1% | — | — |
| LGND | SELL · 10b5-1 | 2026-09-03 | 2026-09-08 | $286.09 | $1.4M | -2.2% | +1.9% | — |
| LGND | SELL · 10b5-1 | 2026-08-03 | 2026-08-04 | $288.99 | $1.4M | -3.1% | -5.0% | — |
| LGND | SELL · 10b5-1 | 2026-07-01 | 2026-07-06 | $313.28 | $1.6M | -8.2% | -6.5% | -5.0% |
| LGND | SELL · 10b5-1 | 2026-06-01 | 2026-06-02 | $227.06 | $1.1M | +9.4% | +36.7% | +21.7% |
| LGND | SELL · 10b5-1 | 2026-05-01 | 2026-05-04 | $231.31 | $1.2M | -5.5% | +0.9% | +25.9% |
| LGND | SELL · 10b5-1 | 2026-04-01 | 2026-04-02 | $201.24 | $1.0M | +12.8% | +14.4% | +56.4% |
| LGND | SELL | 2026-03-04 | 2026-03-06 | $206.35 | $1.0M | +3.9% | +1.0% | +17.0% |
| LGND | SELL | 2025-06-23 | 2025-06-24 | $114.08 | $57K | -3.8% | +12.3% | +44.4% |
| LGND | SELL | 2025-06-10 | 2025-06-12 | $114.54 | $57K | +2.9% | +12.9% | +47.6% |
| LGND | SELL | 2025-05-15 | 2025-06-02 | $104.00 | $104K | +13.0% | +12.2% | +61.6% |
| LGND | SELL | 2024-09-23 | 2024-09-25 | $99.60 | $199K | +2.9% | +12.1% | +13.7% |
| LGND | SELL | 2024-08-28 | 2024-08-30 | $106.39 | $160K | -2.8% | -4.7% | +15.6% |
| LGND | SELL | 2024-05-09 | 2024-05-13 | $83.04 | $1.7M | +0.4% | -5.2% | +17.8% |
| LGND | SELL | 2023-03-24 | 2023-03-28 | $69.92 | $21K | -1.4% | +4.5% | -2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.